Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Hoffman

Showing results (31-40 of 204) with videos related to

Pageof 21
Sort By:
Clinical Advances in Hematology & Oncology : H&O|July 8, 2022
JAK inhibitors in the treatment of myelofibrosisHannah Levavi, Ronald Hoffman, Bridget K Marcellino
JAMA|November 18, 2024
Diagnosis and Treatment of Polycythemia Vera: A ReviewDouglas Tremblay, Marina Kremyanskaya, John Mascarenhas, et al.
Blood|November 25, 2020
Clinical insights into the origins of thrombosis in myeloproliferative neoplasmsAlison R Moliterno, Yelena Z Ginzburg, Ronald Hoffman
Clinical Epigenetics|June 19, 2012
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategiesJohn Mascarenhas, Nitin Roper, Pratima Chaurasia, et al.
Blood|March 11, 2011
The renaissance of interferon therapy for the treatment of myeloid malignanciesJean-Jacques Kiladjian, Ruben A Mesa, Ronald Hoffman
American Journal of Clinical Pathology|May 19, 2005
Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosisHongyu Ni, Giovanni Barosi, Damiano Rondelli, et al.
Experimental Hematology|August 6, 2002
Primate skeletal muscle contains cells capable of sustaining in vitro hematopoiesisNadim Mahmud, Paul Weiss, Fei Li, et al.
Current Opinion in Hematology|February 2, 2023
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosisShivani Handa, Yelena Ginzburg, Ronald Hoffman, et al.
Cancer Management and Research|December 29, 2010
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasmsJoseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al.
Blood|June 8, 2006
Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia veraTakefumi Ishii, Edward Bruno, Ronald Hoffman, et al.
Pageof 21

Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
Clinical Advances in Hematology & Oncology : H&O|July 8, 2022
JAK inhibitors in the treatment of myelofibrosisHannah Levavi, Ronald Hoffman, Bridget K Marcellino
JAMA|November 18, 2024
Diagnosis and Treatment of Polycythemia Vera: A ReviewDouglas Tremblay, Marina Kremyanskaya, John Mascarenhas, et al.
Blood|November 25, 2020
Clinical insights into the origins of thrombosis in myeloproliferative neoplasmsAlison R Moliterno, Yelena Z Ginzburg, Ronald Hoffman
Clinical Epigenetics|June 19, 2012
Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategiesJohn Mascarenhas, Nitin Roper, Pratima Chaurasia, et al.
Blood|March 11, 2011
The renaissance of interferon therapy for the treatment of myeloid malignanciesJean-Jacques Kiladjian, Ruben A Mesa, Ronald Hoffman
American Journal of Clinical Pathology|May 19, 2005
Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosisHongyu Ni, Giovanni Barosi, Damiano Rondelli, et al.
Experimental Hematology|August 6, 2002
Primate skeletal muscle contains cells capable of sustaining in vitro hematopoiesisNadim Mahmud, Paul Weiss, Fei Li, et al.
Current Opinion in Hematology|February 2, 2023
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosisShivani Handa, Yelena Ginzburg, Ronald Hoffman, et al.
Cancer Management and Research|December 29, 2010
Frequency of heterozygous TET2 deletions in myeloproliferative neoplasmsJoseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al.
Blood|June 8, 2006
Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia veraTakefumi Ishii, Edward Bruno, Ronald Hoffman, et al.
Pageof 21